Amazon Japan has submitted a plan to the Japan Fair Trade Commission (JFTC) on how it will improve practices after being suspected of violating anti-trust rules.
The improvement plan includes refunding suppliers who were pressured to pay part of the cost of selling their products at a discount on amazon.com.
If the JFTC approves the plan, the online seller gets exempted from penalties for anti-trust law violations.
The JFTC raided Amazon Japan in 2018 on the suspicion that it demanded “cooperation money” from suppliers.
Amazon Japan had previously been found by the JFTC of requiring suppliers that sell on multiple platforms to list their products on Amazon.com at the same or lower prices.
Amazon Japan agreed to drop the practice that led the regulators in ending the probe in 2017.


Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10%
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



